Fundai

Jaber Ebne Hayyan Pharmaceutical Company (DJABER) monthly reports

The company's monthly activity report on Codal: production and sales, raw materials, energy and foreign currency

Ticker
DJABER
Industry
Pharmaceuticals
Market
Tehran Stock Exchange

Latest periods

Sales amount, 1-month periods
ItemUnitTo 1405/06/31To 1405/05/31To 1405/04/31To 1405/03/31To 1405/02/31To 1405/01/31
Tablets and capsulesmillion rials876,6732,751,976980,1751,603,4611,577,371866,872
Vialmillion rials4,140,7552,706,0994,789,6013,510,3702,284,9103,567,153
Spraymillion rials1,804,384383,49234,71187,944375,6420
Contract manufacturingmillion rials641,012472,136439,301751,762590,04125,432
Discountsmillion rials-215,618-150,000-104,874-221,609-105,751-153,000
Total domestic salesmillion rials6,821,8126,299,6766,046,0965,478,0534,576,2454,602,036
Totalmillion rials7,211,8236,306,2156,100,5956,008,2065,022,1474,431,265
Total export salesmillion rials000000
Total service revenuemillion rials641,012472,136439,301751,762590,04125,432
Total sales returnsmillion rials-35,383-315,597-279,9280-38,388-43,203

Reporting periods

120 periods are on file for this report, from the period ending 1395/07/30 to the period ending 1405/06/31.